| Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging S Sheikhbahaei, A Afshar-Oromieh, M Eiber, LB Solnes, MS Javadi, ... European journal of nuclear medicine and molecular imaging 44, 2117-2136, 2017 | 268 | 2017 |
| Efficacy and safety of high-specific-activity 131I-MIBG therapy in patients with advanced pheochromocytoma or paraganglioma DA Pryma, BB Chin, RB Noto, JS Dillon, S Perkins, L Solnes, ... Journal of Nuclear Medicine 60 (5), 623-630, 2019 | 245 | 2019 |
| 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic … S Vallabhajosula, A Nikolopoulou, JW Babich, JR Osborne, ST Tagawa, ... Journal of Nuclear Medicine 55 (11), 1791-1798, 2014 | 172 | 2014 |
| Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis JC Probasco, L Solnes, A Nalluri, J Cohen, KM Jones, E Zan, MS Javadi, ... Neurology: Neuroimmunology & Neuroinflammation 4 (4), e352, 2017 | 162 | 2017 |
| Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors MA Gorin, SP Rowe, AS Baras, LB Solnes, MW Ball, PM Pierorazio, ... European urology 69 (3), 413-416, 2016 | 160 | 2016 |
| A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new? S Vallabhajosula, L Solnes, B Vallabhajosula Seminars in nuclear medicine 41 (4), 246-264, 2011 | 159 | 2011 |
| Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a call to arms RAS Fragomeni, T Amir, S Sheikhbahaei, SC Harvey, MS Javadi, ... Journal of Nuclear Medicine 59 (6), 871-877, 2018 | 146 | 2018 |
| Diagnostic value of 18F-FDG PET/CT versus MRI in the setting of antibody-specific autoimmune encephalitis LB Solnes, KM Jones, SP Rowe, P Pattanayak, A Nalluri, A Venkatesan, ... Journal of Nuclear Medicine 58 (8), 1307-1313, 2017 | 135 | 2017 |
| The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer S Sheikhbahaei, E Mena, A Yanamadala, S Reddy, LB Solnes, ... American Journal of Roentgenology 208 (2), 420-433, 2017 | 116 | 2017 |
| Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk … MA Gorin, SP Rowe, HD Patel, I Vidal, M Mana-Ay, MS Javadi, LB Solnes, ... The Journal of urology 199 (1), 126-132, 2018 | 112 | 2018 |
| Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study C Huang, LD Ravdin, MJ Nirenberg, P Piboolnurak, L Severt, ... Dementia and Geriatric Cognitive Disorders 35 (3-4), 183-196, 2013 | 105 | 2013 |
| Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls S Sheikhbahaei, RA Werner, LB Solnes, KJ Pienta, MG Pomper, ... Seminars in nuclear medicine 49 (4), 255-270, 2019 | 100 | 2019 |
| Decreased occipital lobe metabolism by FDG-PET/CT: An anti–NMDA receptor encephalitis biomarker JC Probasco, L Solnes, A Nalluri, J Cohen, KM Jones, E Zan, MS Javadi, ... Neurology: Neuroimmunology & Neuroinflammation 5 (1), e413, 2017 | 98 | 2017 |
| Generative adversarial networks for the creation of realistic artificial brain magnetic resonance images K Kazuhiro, RA Werner, F Toriumi, MS Javadi, MG Pomper, LB Solnes, ... Tomography 4 (4), 159-163, 2018 | 87 | 2018 |
| The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go? RA Werner, A Weich, M Kircher, LB Solnes, MS Javadi, T Higuchi, ... Theranostics 8 (22), 6088, 2018 | 73 | 2018 |
| A systematic review and meta-analysis of the effectiveness and toxicities of lutetium-177–labeled prostate-specific membrane antigen–targeted radioligand therapy in metastatic … MS Sadaghiani, S Sheikhbahaei, RA Werner, KJ Pienta, MG Pomper, ... European urology 80 (1), 82-94, 2021 | 71 | 2021 |
| SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: a proposed standardization framework RA Werner, LB Solnes, MS Javadi, A Weich, MA Gorin, KJ Pienta, ... Journal of Nuclear Medicine 59 (7), 1085-1091, 2018 | 66 | 2018 |
| Prostate-specific membrane antigen–targeted imaging with [18F] DCFPyL in high-grade gliomas RAS Fragomeni, JR Menke, M Holdhoff, C Ferrigno, JJ Laterra, LB Solnes, ... Clinical nuclear medicine 42 (10), e433-e435, 2017 | 65 | 2017 |
| 18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies S Sheikhbahaei, KM Jones, RA Werner, RA Salas-Fragomeni, CV Marcus, ... Annals of nuclear medicine 33, 351-361, 2019 | 64 | 2019 |
| Theranostics: leveraging molecular imaging and therapy to impact patient management and secure the future of nuclear medicine LB Solnes, RA Werner, KM Jones, MS Sadaghiani, CR Bailey, C Lapa, ... Journal of Nuclear Medicine 61 (3), 311-318, 2020 | 56 | 2020 |
